128 related articles for article (PubMed ID: 1376619)
21. Serum lactate dehydrogenase isoenzyme 1 and tumour volume are indicators of response to treatment and predictors of prognosis in metastatic testicular germ cell tumours.
von Eyben FE; Blaabjerg O; Madsen EL; Petersen PH; Smith-Sivertsen C; Gullberg B
Eur J Cancer; 1992; 28(2-3):410-5. PubMed ID: 1375486
[TBL] [Abstract][Full Text] [Related]
22. [Determination of specific markers in the blood in tumors of the testis].
Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
[No Abstract] [Full Text] [Related]
23. Use of carboplatin in germ cell tumors of the testis.
Horwich A; Mason M; Dearnaley DP
Semin Oncol; 1992 Feb; 19(1 Suppl 2):72-7. PubMed ID: 1329224
[TBL] [Abstract][Full Text] [Related]
24. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
25. Testicular germ cell tumours. Current problems of histogenesis and classification.
Kiss F; Juhász J
Int Urol Nephrol; 1985; 17(1):85-95. PubMed ID: 2581914
[TBL] [Abstract][Full Text] [Related]
26. Acclerated growth of testicular cancer after cytoreductive surgery.
Lange PH; Hekmat K; Bosl G; Kennedy BJ; Fraley EE
Cancer; 1980 Mar; 45(6):1498-506. PubMed ID: 6153570
[TBL] [Abstract][Full Text] [Related]
27. The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metastatic nonseminomatous germ cell tumours of the testis.
Childs WJ; Nicholls EJ; Horwich A
Ann Oncol; 1992 Apr; 3(4):291-6. PubMed ID: 1382552
[TBL] [Abstract][Full Text] [Related]
28. [Histopathology of testicular germ cell tumors].
Morinaga S; Sasano N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
[TBL] [Abstract][Full Text] [Related]
29. [Value of tumor marker positivity in germinal non-seminomatous tumors of the testis].
Bassetto MA; Franceschi T; Lenotti M; Pancheri F; Zaninelli M; Corgnati A; Cetto GL
J Nucl Med Allied Sci; 1990; 34(4 Suppl):89-90. PubMed ID: 1709212
[No Abstract] [Full Text] [Related]
30. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
31. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
[TBL] [Abstract][Full Text] [Related]
32. Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours.
Horwich A; Brada M; Nicholls J; Jay G; Hendry WF; Dearnaley D; Peckham MJ
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):177-84. PubMed ID: 2467806
[TBL] [Abstract][Full Text] [Related]
33. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
Uysal Z; Bakkaloğlu M
Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261
[TBL] [Abstract][Full Text] [Related]
34. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
35. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
36. The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
Price P; Hogan SJ; Bliss JM; Horwich A
Eur J Cancer; 1990 Apr; 26(4):453-7. PubMed ID: 1694087
[TBL] [Abstract][Full Text] [Related]
37. Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.
Yamamoto H; Rudén U; Esposti P; Hirano K; Stigbrand T; Andersson L; Hisazumi H; Wahren B
Urol Res; 1988; 16(1):31-6. PubMed ID: 2449757
[TBL] [Abstract][Full Text] [Related]
38. Single agent activity of methotrexate in advanced non-seminomatous testicular germ cell tumours.
Smith DB; Rustin GJ; Hitchins R; Bagshawe KD; Hoskins P
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1779-81. PubMed ID: 2850192
[TBL] [Abstract][Full Text] [Related]
39. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
40. Treatment of seminoma.
Horwich A; Dearnaley DP
Semin Oncol; 1992 Apr; 19(2):171-80. PubMed ID: 1372759
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
